Etiology-Specific, Lipid-Augmented BISAP for Early Risk Stratification in Hypertriglyceridemic Acute Pancreatitis: A Multicenter Retrospective Study

INTRODUCTION: Hypertriglyceridemic acute pancreatitis (HTG-AP) is an increasingly prevalent condition that carries a high risk of progression to severe HTG-AP (HTG-SAP) with organ failure (OF). However, widely used early severity scoring systems such as the BISAP score do not incorporate lipid-related biomarkers, despite the central role of lipid dysregulation in HTG-AP pathogenesis. This study aimed to evaluate whether incorporating apolipoprotein A-I (Apo A-I) or triglyceride (TG) levels into the BISAP score, creating lipid-augmented models, could enhance early prediction of adverse clinical outcomes. METHODS: We retrospectively included 275 HTG-AP patients from two tertiary centers. Serum lipid profiles and BISAP scores were recorded within 24 hours of admission. The early predictive performance of lipid-augmented models (BISAP-Apo A I and BISAP-TG) for HTG SAP and OF was compared with BISAP, MCTSI, and CRP using ROC, DeLong's test, IDI, NRI, and DCA. Optimal ROC derived cut offs for each combined model were applied to stratify patients into high and low risk groups, and differences in local and systemic complication rates and hospital length of stay were analyzed. RESULTS: Lower Apo A-I and higher TG levels on admission were significantly associated with HTG-SAP and OF (both P < 0.01). The BISAP-Apo A-I model demonstrated the highest predictive accuracy (AUC = 0.859 for HTG-SAP; 0.766 for OF), significantly outperforming BISAP alone (ΔAUC = 0.054 and 0.041, respectively; both P < 0.05). The BISAP-TG model also improved prediction of HTG-SAP (AUC = 0.850; P < 0.01), though its benefit for OF was borderline (ΔAUC = 0.035; P = 0.051). Both models outperformed CRP for HTG-SAP; for OF, only BISAP-Apo A-I did so significantly, whereas BISAP-TG did not (P=0.058). Compared with MCTSI, BISAP-Apo A-I showed numerically higher AUCs, although the differences did not reach statistical significance (P = 0.179 for HTG-SAP; P = 0.696 for OF). DCA demonstrated broadly comparable net benefit between the lipid-augmented models and the original BISAP score across most threshold probability ranges. Using ROC-derived thresholds (0.27 for BISAP-Apo A-I; 0.13 for BISAP-TG), early stratification effectively identified high-risk patients who experienced significantly more local/systemic complications and longer hospital stays (both P < 0.01). CONCLUSION: Lipid-augmented BISAP models improved early prognostic accuracy for HTG-AP. By integrating etiology-specific lipid biomarkers, these models enable timely identification of high-risk patients who may benefit from closer monitoring and earlier intervention.

Authors

Publication Details

Journal
Digestion
Published
2026-11-18
DOI
https://doi.org/10.1159/dig/acmag039
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Etiology-Specific, Lipid-Augmented BISAP for Early Risk Stratification in Hypertriglyceridemic Acute Pancreatitis: A Multicenter Retrospective Study

Meiru Liu, Ziyu Liu, Yingqi Wang, Huihong Zhai et al.
5 links
Digestion
Pancreatitis Pathology and Treatment
article

Etiology-Specific, Lipid-Augmented BISAP for Early Risk Stratification in Hypertriglyceridemic Acute Pancreatitis: A Multicenter Retrospective Study

Meiru Liu, Ziyu Liu, Yingqi Wang, Huihong Zhai, Shan Hong, Zhuo Chen, Shuiqing Hu, Xiaocui Li, Lijie Hao, Yage Bu, Dandan Zhao
article en

Abstract

INTRODUCTION: Hypertriglyceridemic acute pancreatitis (HTG-AP) is an increasingly prevalent condition that carries a high risk of progression to severe HTG-AP (HTG-SAP) with organ failure (OF). However, widely used early severity scoring systems such as the BISAP score do not incorporate lipid-related biomarkers, despite the central role of lipid dysregulation in HTG-AP pathogenesis. This study aimed to evaluate whether incorporating apolipoprotein A-I (Apo A-I) or triglyceride (TG) levels into the BISAP score, creating lipid-augmented models, could enhance early prediction of adverse clinical outcomes. METHODS: We retrospectively included 275 HTG-AP patients from two tertiary centers. Serum lipid profiles and BISAP scores were recorded within 24 hours of admission. The early predictive performance of lipid-augmented models (BISAP-Apo A I and BISAP-TG) for HTG SAP and OF was compared with BISAP, MCTSI, and CRP using ROC, DeLong's test, IDI, NRI, and DCA. Optimal ROC derived cut offs for each combined model were applied to stratify patients into high and low risk groups, and differences in local and systemic complication rates and hospital length of stay were analyzed. RESULTS: Lower Apo A-I and higher TG levels on admission were significantly associated with HTG-SAP and OF (both P < 0.01). The BISAP-Apo A-I model demonstrated the highest predictive accuracy (AUC = 0.859 for HTG-SAP; 0.766 for OF), significantly outperforming BISAP alone (ΔAUC = 0.054 and 0.041, respectively; both P < 0.05). The BISAP-TG model also improved prediction of HTG-SAP (AUC = 0.850; P < 0.01), though its benefit for OF was borderline (ΔAUC = 0.035; P = 0.051). Both models outperformed CRP for HTG-SAP; for OF, only BISAP-Apo A-I did so significantly, whereas BISAP-TG did not (P=0.058). Compared with MCTSI, BISAP-Apo A-I showed numerically higher AUCs, although the differences did not reach statistical significance (P = 0.179 for HTG-SAP; P = 0.696 for OF). DCA demonstrated broadly comparable net benefit between the lipid-augmented models and the original BISAP score across most threshold probability ranges. Using ROC-derived thresholds (0.27 for BISAP-Apo A-I; 0.13 for BISAP-TG), early stratification effectively identified high-risk patients who experienced significantly more local/systemic complications and longer hospital stays (both P < 0.01). CONCLUSION: Lipid-augmented BISAP models improved early prognostic accuracy for HTG-AP. By integrating etiology-specific lipid biomarkers, these models enable timely identification of high-risk patients who may benefit from closer monitoring and earlier intervention.

Digestion
Good health and well-being
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon